Piramal Enterprise has fallen 38 % from its peak.
It has bounced from its long term monthly support .
It has formed nice base and now the price is breaking out.
For a target of 2070 it has upside of nearly 20 percent.
Stop loss can be kept at 1670 (4.3 % below the current market price)
20 / 50 MA firmly behind the price should give good support.
Risk Reward of...
Ok so, got confirmation by abhishek bhai.. I will gonna take entry on Monday, looks good for first around 3% and then around 16% is possible in this script according to support and resistance.. it can go move upside, actually it already has made bullish reversal and now continuation after this last pullback on daily chart, Sl is just below this current...
Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries. The Company's pharmaceutical business consists of manufacturing and sale of own and traded bulk drugs and formulations. It operates through three segments: Healthcare, Financial Services and Information Management. Its Healthcare segment includes pharma solutions, critical care, consumer products and imaging. Its Financial Services segment includes wholesale lending, alternative asset management and investments in Shriram Group. Its Information Management segment is engaged in Decision Resources Group (DRG). DRG's product and services portfolio consists of data and analytics, research products and global consulting services. The Company offers its products under brands, including Saridon, Lacto Calamine, i-pill/i-know, Polycrol, Tetmosol, Untox, Stop AllerG and Throatsil.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
PEL
